Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2025-12-24 @ 2:47 PM
NCT ID:
NCT01429259
Eligibility Criteria:
Inclusion Criteria:
* Cystic Fibrosis
* Hospitalized with acute pulmonary exacerbation
* Caused by Pseudomonas aeruginosa or other bacteria against which meropenem would be an appropriate antibiotic treatment
Exclusion Criteria:
* Known allergy to meropenem
* Require less than 3 days of meropenem in the hospital
* Require another systemic Beta-lactam antibiotic to treat a concomitant pathogen
* Known fungal or viral infection
* Females in their 2nd or 3rd trimester of pregnancy
* Moderate to severe renal dysfunction, as defined by a creatinine clearance less than 50 ml/min/1.73m2 (by use of Schwartz method)
* History of solid organ transplantation within previous 6 months
* Active or recent (within 30 days) participation in another antibiotic clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
17 Years
Study:
NCT01429259
Study Brief:
Protocol Section:
NCT01429259